Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Beijing Anzhen Hospital is the lead sponsor of 78 current clinical trials in our China register. 44 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Colchicine Pill, Tirofiban and Ulinastatin. The most-studied condition is Atrial Fibrillation (AF).

ClinicalTrials.gov trials by status

Recruiting4456%
Not yet open2532%
Active, closed79%
By invitation23%

Trials by phase

Observational3747%
Not applicable3444%
Phase 445%
Phase 323%
Phase 2/311%

Clinical trials sponsored by Beijing Anzhen Hospital

78 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
China Extracorporeal Life Support Registry NCT04158479 · ClinicalTrials.gov ↗ · Cardiogenic Shock, Cardiac Arrest, Heart Failure	Observational	Recruiting	2017-01	China
A Cohort Study on Increasing Blood Pressure Benefits in Sleep Apnea Patients After CPAP Treatment NCT07357272 · ClinicalTrials.gov ↗ · Hypertension (HTN), Sleep Apnea Syndrome, Obstructive	Observational	Recruiting	2025-09	China
Intracardiac Echocardiography-Guided Cavotricuspid Isthmus Ablation With a Circular-Shaped Pulsed Field Ablation Catheter NCT07353775 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Atrial Flutter	Observational	Recruiting	2025-01	China
Digital Remote Management Versus Usual Care for Optimization of Guideline-directed Medical Therapy in Patients With Heart Failure and Reduced Ejection Fraction: a Multicentre, Randomised, Controlled Trial (DigiCare-HFrEF) NCT07352891 · ClinicalTrials.gov ↗ · Heart Failure With Reduced Ejection Fraction	Not applicable	Recruiting	2026-02	China
Basic and Clinical Study of Cardiac Ganglion Catheter Ablation for the Treatment of Significant Bradycardia NCT07468383 · ClinicalTrials.gov ↗ · Symptomatic Bradycardia, Autonomic Nervous System Diseases	Not applicable	Recruiting	2025-08	China
Complex Arrhythmia Registry NCT07024927 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Ventricular Tachycardia (VT)	Observational	Recruiting	2025-10	China
An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease NCT06768008 · ClinicalTrials.gov ↗ · Congenital Heart Disease, Coarctation of Aorta, Aortic Stenosis	Observational	Recruiting	2022-01	China
Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation NCT06842147 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Not applicable	Recruiting	2025-03	China
SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF) NCT07316270 · ClinicalTrials.gov ↗ · AF - Atrial Fibrillation, Intracranial Hemorrhage, Spontaneous	Not applicable	Recruiting	2026-05	China
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine NCT06215989 · ClinicalTrials.gov ↗ · Acute Coronary Syndrome, Unstable Angina, ST Elevation Myocardial Infarction Drug: Colchicine Pill	Not applicable	Recruiting	2024-09	China
Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis NCT04968509 · ClinicalTrials.gov ↗ · Aortic Stenosis	Phase 3	Recruiting	2024-03	China
A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis NCT07034157 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Carotid Artery Stenosis, Cerebrovascular Disorders	Observational	Recruiting	2025-06	China
Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study NCT07149688 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Hypertension, Coronary Heart Disease (CHD)	Observational	Recruiting	2024-03	China
Cardiac Magnetic Resonance - PROgnostic HEart Scar for Sudden Cardiac Death Prediction StudY NCT07137936 · ClinicalTrials.gov ↗ · Sudden Death, Cardiac, Myocardial Scarring, Myocardial Infarction (MI)	Observational	Recruiting	2026-01	China
Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction NCT07820410 · ClinicalTrials.gov ↗ · Heart Failure With Reduced Ejection Fraction (HFrEF)	Phase 2/3	Recruiting	2024-11	China
Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases NCT07012668 · ClinicalTrials.gov ↗ · Neuro-co-cardiological Diseases, Post-cardiac Surgery Cerebrovascular Diseases, Vascular Lesion	Observational	Recruiting	2024-09	China
Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke NCT07290751 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke Drug: Tirofiban	Phase 4	Recruiting	2025-11	China
Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation NCT07444372 · ClinicalTrials.gov ↗ · Obstructive Sleep Apnea, Sleep Disorder (Disorder), Atrial Fibrillation (AF)	Not applicable	Recruiting	2026-05	China
Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques NCT06855537 · ClinicalTrials.gov ↗ · Coronary Arterial Disease (CAD), Vulnerable Coronary Plaques, Thin-cap fIbroatheroma	Phase 4	Recruiting	2025-11	China
Helium-free Magnetocardiography Guided Therapy for Stable Coronary Artery Disease - A Randomized Controlled Trial NCT07341932 · ClinicalTrials.gov ↗ · Stable Coronary Artery Disease CAD	Not applicable	Recruiting	2026-03	China
Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly NCT07403760 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Not applicable	Recruiting	2026-07	China
Effect of Balloon Angioplasty vs Stenting Following Residual Stenosis After Endovascular Treatment of Intracranial Atherosclerotic Acute Ischemic Stroke NCT07026331 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke, Intracranial Atherosclerosis ICAS	Not applicable	Recruiting	2025-07	China
Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic Stroke NCT07026318 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke Drug: Tirofiban	Not applicable	Recruiting	2025-08	China
Prospective Registry of the Current Status of Care for Patients With Coronary Artery Disease NCT05337319 · ClinicalTrials.gov ↗ · Coronary Artery Disease	Observational	Recruiting	2022-01	China
Smartwatch-based Intervention for Cardiovascular Health (SWITCH) NCT07372729 · ClinicalTrials.gov ↗ · Prehypertension, Borderline Dyslipidemia, Overweight , Obesity	Not applicable	Recruiting	2026-03	China
Marshall Vein Ethanol Infusion in Addition to Pulsed Electric Field Ablation Versus Pulsed Electric Field Ablation Alone for Paroxysmal Atrial Fibrillation NCT07095959 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Not applicable	Recruiting	2025-07	China
Balloon Guide Catheter Combined With Filter Protection for Carotid Artery Stenting NCT07247864 · ClinicalTrials.gov ↗ · Carotid Artery Stenosis	Not applicable	Recruiting	2025-12	China
Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial NCT06883864 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Catheter Ablation, Atrial Functional Mitral Regurgitation	Not applicable	Recruiting	2025-04	China
Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation NCT06871228 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Not applicable	Recruiting	2025-08	China
Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection NCT07150559 · ClinicalTrials.gov ↗ · Acute Type A Aortic Dissection, Hypothermia, Total Aortic Arch Replacement	Not applicable	Recruiting	2026-02	China
Digital Remote Management for Care and Continuous Optimization Versus Usual Care to Reduce Risk of Atherosclerotic Cardiovascular Diseases (DigiCare-preASCVD) NCT07332468 · ClinicalTrials.gov ↗ · Atherosclerotic Cardiovascular Diseases	Not applicable	Recruiting	2026-02	China
A Comprehensive Registry Study of the Whole Life Cycle of Patients With CHD NCT06611787 · ClinicalTrials.gov ↗ · Congenital Heart Disease	Observational	Recruiting	2024-02	China
Chinese Atrial Fibrillation Registry NCT06987825 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Observational	Recruiting	2011-08	China
CompaRison of FEmorofemoral Bypass and Left-Heart ByPass Techniques in Open Thoracoabdominal AortIc Aneurysm Repair NCT07518251 · ClinicalTrials.gov ↗ · Thoracoabdominal Aortic Aneurysm, Cardiopulmonary Bypass, Open Repair	Not applicable	Recruiting	2026-03	China
PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study NCT06336239 · ClinicalTrials.gov ↗ · Cardiovascular Disease, Type 2 Diabetes Mellitus	Observational	Recruiting	2023-12	China
Early Intra-aortic Balloon Pump Use After Venoarterial Extracorporeal Membrane Oxygenation NCT06872021 · ClinicalTrials.gov ↗ · ECMO	Not applicable	Recruiting	2026-03	China
Application of Non-inductive Intelligent Physical Sign Monitoring Equipment Based on Flexible Electronic Devices in the Diagnosis and Treatment of Cardiovascular Diseases NCT07466056 · ClinicalTrials.gov ↗ · Cardiovascular Disease	Observational	Recruiting	2024-10	China
Ventricular Tachycardia：A Registry Study NCT07149701 · ClinicalTrials.gov ↗ · Ventricular Tachycardia (VT), Structural Heart Disease	Observational	Recruiting	2025-10	China
Safety and Efficacy of Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation NCT07414225 · ClinicalTrials.gov ↗ · Atrial Functional Mitral Regurgitation	Not applicable	Recruiting	2026-06	China
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension NCT07607275 · ClinicalTrials.gov ↗ · Hypertension, Essential (Primary) Hypertension	Phase 4	Recruiting	2026-05	China
Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention NCT06274411 · ClinicalTrials.gov ↗ · ECMO, High-risk PCI	Not applicable	Recruiting	2025-03	China
Modifiable Risk Factors for Cognitive Dysfunction in Patients With Coronary Heart Disease NCT07657624 · ClinicalTrials.gov ↗ · Coronary Heart Disease, Cognitive Impairment, Mild	Observational	Recruiting	2025-06	China
Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis NCT06885619 · ClinicalTrials.gov ↗ · Left Ventricular Remodeling, Plasma Multi-Omics, Acute ST-segment Elevation Myocardial Infarction	Observational	Recruiting	2025-05	China
Investigation of Tetralogy of Fallot in Neonates NCT06822400 · ClinicalTrials.gov ↗ · Tetralogy of Fallot (TOF), Pulmonary Stenosis, Ventricular Septal Defects (VSD)	Not applicable	Recruiting	2025-03	China
The Correlation Between Obstructive Sleep Apnea-Related Nocturnal Hypoxemia Parameters and Coronary Microvascular Dysfunction: A Prospective Cohort Study (SLEEP-CMD) NCT07315399 · ClinicalTrials.gov ↗ · OSA - Obstructive Sleep Apnea, Coronary Microvascular Dysfunction (CMD), Coronary Artery Disease (CAD)	Observational	Not yet open	2025-12	China
Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness Assessment NCT07615296 · ClinicalTrials.gov ↗ · Atherosclerotic Cardiovascular Disease (ASCVD)	Not applicable	Not yet open	2027-01	China
Low-dose Colchicine for CABG Graft Failure Prevention NCT07569328 · ClinicalTrials.gov ↗ · CAD - Coronary Artery Disease, CABG, Colchicine Drug: Colchicine Pill	Not applicable	Not yet open	2026-09	China
Safety and Efficacy of Conscious Sedation Versus General Anesthesia in Pulsed-Field Ablation for Paroxysmal Atrial Fibrillation NCT07541339 · ClinicalTrials.gov ↗ · Atrial Fibrillation (Paroxysmal)	Not applicable	Not yet open	2026-04	China
Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome NCT04184583 · ClinicalTrials.gov ↗ · Drug Therapy, Acute Coronary Syndrome	Observational	Not yet open	2019-12	China
Comprehensive Care of Sleep Disordered Breathing NCT07339371 · ClinicalTrials.gov ↗ · Sleep Disordered Breathing (SDB)	Observational	Not yet open	2026-01	China
CLEAR Trial: CA330 Cytokine Adsorption Column for Anticoagulant/Antiplatelet Patients in Non-Elective CPB Surgery. NCT07284199 · ClinicalTrials.gov ↗ · CABG, Aortic Dissection, Valvular Heart Diseases	Not applicable	Not yet open	2025-12	China
A Multicenter Study of Artificial Intelligence Model for Fetal Congenital Heart Disease NCT06796127 · ClinicalTrials.gov ↗ · Congenital Heart Disease (CHD), Artificial Intelligence (AI)	Observational	Not yet open	2025-02	China
Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease NCT07605624 · ClinicalTrials.gov ↗ · Aortic Stenosis, Aortic Regurgitation, Mitral Regurgitation	Observational	Not yet open	2026-05	China
Prospective Study on the Effectiveness and Safety of Bi-polar Pulse-field Tip-catheter Ablation for Atrial Fibrillation in China（POTENTIAL-AF） NCT07627685 · ClinicalTrials.gov ↗ · Atrial Fibrillation	Observational	Not yet open	2026-09	China
PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis NCT07256197 · ClinicalTrials.gov ↗ · Aortic Stenosis, Calcific	Phase 3	Not yet open	2026-04	China
Angiography-Derived Physiological Indices for Outcome Prediction in Patients Undergoing OCT-Guided PCI NCT07511231 · ClinicalTrials.gov ↗ · Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))	Observational	Not yet open	2026-04	China
Safety and Efficacy of a Novel Composite-Tip Guiding Catheter in Transcarotid Artery Stenting Via Transradial Access NCT07377422 · ClinicalTrials.gov ↗ · Transradial Carotid Artery Stenting, Novel Composite-tip Guiding Catheter	Not applicable	Not yet open	2026-01	China
For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure, Avoiding a Return Hospital Visit for a Second Operation. NCT07264881 · ClinicalTrials.gov ↗ · Microvascular Obstruction (MVO), Multivessel Coronary Artery Disease, ACS (Acute Coronary Syndrome)	Observational	Not yet open	2025-12	China
Cohort Study of Postoperative Cognitive Dysfunction After Off-Pump Coronary Artery Bypass Grafting NCT07643194 · ClinicalTrials.gov ↗ · Postoperative Cognitive Dysfunction (POCD)	Observational	Not yet open	2026-05	China
Catheter Ablation of Haemodynamically Not-tolerated Electrical Storm in Structural Heart Disease NCT06455020 · ClinicalTrials.gov ↗ · Ventricular Tachycardia	Not applicable	Not yet open	2024-07	China
Coronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD) NCT07353762 · ClinicalTrials.gov ↗ · Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))	Observational	Not yet open	2026-01	China
Photoplethysmography (PPG) Algorithm with Smartwatch in Evaluation of Atrial Fibrillation Burden After Catheter Ablation NCT06842160 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Observational	Not yet open	2025-03	China
Population Pharmacokinetics of L-AmB in Chinese Patients Assisted by Extracorporeal Membrane Pulmonary Oxygenation (ECMO) NCT06754436 · ClinicalTrials.gov ↗ · Invasive Fungal Infections, Liposomal Amphotericin B	Phase 4	Not yet open	2025-01	China
Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation NCT06791629 · ClinicalTrials.gov ↗ · Persistent Atrial Fibrillation, Radiofrequency Catheter Ablation, Pulsed Field Ablation	Not applicable	Not yet open	2025-02	China
Arrhythmia Cohort Study NCT07123896 · ClinicalTrials.gov ↗ · Arrhythmia	Observational	Not yet open	2025-08	China
LLM-Based Intelligent Health Management Assistant in Life-Cycle Health Management of Cardiac Surgery Patients NCT07521488 · ClinicalTrials.gov ↗ · Coronary Artery Bypass Grafting, Heart Valve Disease, Aortic Aneurysm	Not applicable	Not yet open	2026-05	China
Digital Remote Management for Care and Continuous Optimization Versus Usual Care in Patients With Coronary Heart Disease (DigiCare-CHD) NCT07332494 · ClinicalTrials.gov ↗ · Coronary Heart Disease, Percutaneous Coronary Intervention	Not applicable	Not yet open	2026-01	China
Accuracy Assessment of a Novel Gas Detection Approach in Dyslipidemia Diagnosis NCT06486857 · ClinicalTrials.gov ↗ · Dyslipidemias, Gas Detection Method	Observational	Not yet open	2024-07	China
Photoplethysmography (PPG) Algorithm With Smartwatch in Evaluation of Atrial Fibrillation Burden NCT06686940 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF)	Observational	Not yet open	2024-12	China
Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis NCT07103863 · ClinicalTrials.gov ↗ · AL Amyloidosis (AL), Cardiac Amyloidosis	Observational	By invitation	2025-02	China
Application of FAPI Visualization in the Assessment of Right Ventricular Dysfunction Due to Volume Overload NCT06663566 · ClinicalTrials.gov ↗ · Right Heart Insufficiency, Tricuspid Regurgitation	Observational	By invitation	2024-08	China
Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE) NCT03783351 · ClinicalTrials.gov ↗ · Angina, Stable, Acute Coronary Syndrome, Drug-Eluting Stents	Not applicable	Active, closed	2019-05	China
Efficacy of Rescue Stenting/Angioplasty After Failed Thrombectomy for Acute Large Intracranial Vascular Occlusion NCT07026344 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Not applicable	Active, closed	2025-07	China
Acute Myocardial Infarction Clinical Intelligent Decision Support System NCT07367399 · ClinicalTrials.gov ↗ · Acute Myocardial Infarction, Large Language Models, Clinical Decision Support System	Observational	Active, closed	2018-01	China
Artificial Intelligence for Ulinastatin Responder Outcome & Risk Assessment in CPB NCT07583290 · ClinicalTrials.gov ↗ · Cardiac Surgical Procedures, Cardiopulmonary Bypass, Systemic Inflammatory Response Syndrome Drug: Ulinastatin	Observational	Active, closed	2018-01	China
AI-Based Risk Factor Analysis and Prediction Model of MACE in Elderly Hip Fracture Patients Postoperatively NCT07709377 · ClinicalTrials.gov ↗ · Hip Fracture, MACE, Elderly	Observational	Active, closed	2025-07	China
Study on Risk Factors and Prognostic Value of Non-target Lesion Progression in Patients With Coronary Artery Disease NCT07748754 · ClinicalTrials.gov ↗ · Coronary Artery Disease (CAD)	Observational	Active, closed	2020-01	China
Peri-procedural Hydration to Prevent Acute Kidney Injury After Pulsed Field Ablation for Atrial Fibrillation NCT07490808 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Acute Kidney Injury	Not applicable	Active, closed	2026-03	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Beijing Anzhen Hospital trials

3 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Colchicine Pill2 Tirofiban2 Ulinastatin1

Conditions in Beijing Anzhen Hospital trials

130 conditions

Atrial Fibrillation (AF)13 Acute Ischemic Stroke4 Acute Coronary Syndrome3 Aortic Stenosis3 Heart Failure2 Coronary Artery Disease (CAD)2CABG2Ventricular Tachycardia (VT)2Congenital Heart Disease2 Coronary Artery Disease2 Carotid Artery Stenosis2Sleep Disordered Breathing (SDB)2Hypertension2 Aortic Dissection2 Tricuspid Regurgitation2 Cardiopulmonary Bypass2Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))2Atrial Functional Mitral Regurgitation2Cardiovascular Disease2ECMO2Coronary Heart Disease2Cardiogenic Shock1Cardiac Arrest1 Acute Respiratory Distress Syndrome1

By trial register

Register	Trials	Recruiting
Clinical trials in China	78	44

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Atrial Fibrillation (AF)

Sponsor	Trials
Shanghai Chest Hospital	6
Second Affiliated Hospital of Nanchang University	2
Jiangsu Taizhou People's Hospital	2
Hangzhou Dinova EP Technology	2
Lanzhou University Second Hospital	1

Sponsors with the most current trials registered for this condition.

Questions about Beijing Anzhen Hospital trials

How many clinical trials does Beijing Anzhen Hospital sponsor?

Beijing Anzhen Hospital is the lead sponsor of 78 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Beijing Anzhen Hospital trials recruiting?

Yes. 44 of its 78 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Beijing Anzhen Hospital testing?

Its current trials name 3 drugs and biologicals as interventions. The most frequent are Colchicine Pill (2), Tirofiban (2) and Ulinastatin (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Beijing Anzhen Hospital clinical trials